Aurora Cannabis Property, Plant, and Equipment 2017-2024 | ACB
Aurora Cannabis property, plant, and equipment from 2017 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
| Aurora Cannabis Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024 | $218 |
| 2022 | $184 |
| 2021 | $473 |
| 2020 | $706 |
| 2019 | $578 |
| 2018 | $194 |
| 2017 | $34 |
| 2017 | $0 |
| 2016 | $0 |
| Aurora Cannabis Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024-12-31 | $193 |
| 2024-09-30 | $203 |
| 2024-06-30 | $207 |
| 2024-03-31 | $218 |
| 2023-12-31 | $217 |
| 2023-09-30 | $229 |
| 2023-06-30 | $229 |
| 2022-12-31 | $235 |
| 2022-09-30 | $245 |
| 2022-03-31 | $271 |
| 2021-12-31 | $456 |
| 2021-09-30 | $469 |
| 2021-03-31 | $535 |
| 2020-12-31 | $547 |
| 2020-09-30 | $704 |
| 2020-03-31 | $787 |
| 2019-12-31 | $759 |
| 2019-09-30 | $737 |
| 2019-03-31 | $472 |
| 2018-12-31 | $404 |
| 2018-09-30 | $344 |
| 2018-06-30 | |
| 2018-03-31 | $151 |
| 2017-12-31 | $92 |
| 2017-09-30 | $57 |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.309B | $0.200B |
| Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.440B | 27.47 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $143.752B | 30.06 |
| EssilorLuxottica (ESLOY) | France | $130.179B | 0.00 |
| Medtronic (MDT) | Ireland | $103.476B | 14.67 |
| Haleon (HLN) | United Kingdom | $50.205B | 28.56 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.251B | 0.00 |
| ResMed (RMD) | United States | $35.607B | 26.74 |
| GE HealthCare Technologies (GEHC) | United States | $31.667B | 15.03 |
| Agilent Technologies (A) | United States | $30.942B | 20.44 |
| Terumo (TRUMY) | Japan | $27.686B | 35.96 |
| Insulet (PODD) | United States | $22.616B | 88.77 |
| Koninklijke Philips (PHG) | Netherlands | $21.196B | 15.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.329B | 11.77 |
| Baxter (BAX) | United States | $15.457B | 11.54 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.539B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.090B | 21.19 |
| Lantheus Holdings (LNTH) | United States | $5.110B | 12.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.237B | 18.93 |
| Perrigo (PRGO) | Ireland | $3.651B | 9.25 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.175B | 23.41 |
| Haemonetics (HAE) | United States | $3.173B | 14.46 |
| Envista Holdings (NVST) | United States | $2.834B | 23.55 |
| GN Store Nord (GNNDY) | Denmark | $2.054B | 17.01 |
| QuidelOrtho (QDEL) | United States | $2.011B | 13.83 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.11 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.315B | 16.83 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.185B | 12.03 |
| Green Thumb Industries (GTBIF) | United States | $1.145B | 25.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.035B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.04 |
| InMode (INMD) | Israel | $0.899B | 9.06 |
| Evolus (EOLS) | United States | $0.624B | 0.00 |
| CeriBell (CBLL) | United States | $0.599B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.569B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Owens & Minor (OMI) | United States | $0.498B | 4.13 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Surmodics (SRDX) | United States | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.336B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.326B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Sanara MedTech (SMTI) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.231B | 10.48 |
| Brainsway (BWAY) | Israel | $0.203B | 53.65 |
| Biote (BTMD) | United States | $0.201B | 5.66 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.185B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.179B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.175B | 14.22 |
| Exagen (XGN) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 16.86 |
| Jin Medical (ZJYL) | China | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.058B | 0.00 |
| United Health Products (UEEC) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.71 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |